(Q35669533)

9 August 2017

Development of new antivirals for herpesviruses (English)

1 reference

9 August 2017

Yoshito Eizuru

1

1 reference

9 August 2017

1 November 2003

1 reference

Antiviral Chemistry & Chemotherapy

9 August 2017

1 reference

9 August 2017

14

1 reference

9 August 2017

6

1 reference

9 August 2017

299-308

1 reference

The antiviral agent 5-chloro-1,3-dihydroxyacridone interferes with assembly and maturation of herpes simplex virus

9 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Mechanism of action of foscarnet against viral polymerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

New anti-HSV therapeutics target the helicase-primase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

The biochemistry and mechanism of action of acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Reactivation and role of HHV-8 in Kaposi's sarcoma initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

The UL6 gene product forms the portal for entry of DNA into the herpes simplex virus capsid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

In vitro assembly of the herpes simplex virus procapsid: formation of small procapsids at reduced scaffolding protein concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Inhibition of herpes simplex virus replication by WAY-150138: assembly of capsids depleted of the portal and terminase proteins involved in DNA encapsidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Clinical aspects and management of cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Pharmacokinetics and absorption of foscarnet after intravenous and oral administration to patients with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

DNA encapsidation as a target for anti-herpesvirus drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Non-nucleoside inhibitors of herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Identification of novel herpes simplex virus replicative intermediates by field inversion gel electrophoresis: implications for viral DNA amplification strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020301400602

10.1177/095632020301400602

21 January 2018

Identifiers

DOI

1 reference

release_nh5cgxykmzep3bhto6mqpnub2m

9 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nh5cgxykmzep3bhto6mqpnub2m

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

14968936

1 reference

PubMed ID

14968936